GSK wins latest trial over Zantac cancer claims

GSK (GSK.L) won the latest trial over claims that discontinued heartburn drug Zantac caused cancer, as a jury on Monday found that the drug was not responsible for an Illinois woman's illness, a company spokesperson said.